You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
NO
YES

HIGHLIGHTS

CORPORATE

A chat with Val Romberg

Kedrion Biopharma's new CEO shares his views

read more 

EVENTS

Turkey, Kedrion supports the XVII International Congress on Hemophilia

The present and future role of Factor VIII at the center of the symposium supported by Kedrion

read more 

EVENTS

Kedrion is one of the main sponsors of the National SISET Conference

The company sponsors two scientific lectures, a testament to its close ties with the world of medicine and science

read more 
  1. CORPORATE - 06-10-2020

    Kedrion announces the appointment of a new CEO

    Val Romberg from the USA, one of the most esteemed managers in the industry

    read more 
  2. EVENTS - 02-10-2020

    Kedrion supports the 2020 European Hemophilia Consortium Conference

    The company renews its commitment alongside the EHC, which continues to support the PARTNERS project

    read more 
  3. CORPORATE - 01-09-2020

    KEDPLASMA GmbH changes its name to Kedrion Biopharma GmbH

    Further step towards an even stronger focus on patients in Europe

    read more 
  4. PLASMA & BIOTHERAPIES - 21-08-2020

    First and Only US Pediatric human rabies Immune globulin Trial

    Kedrion-Kamada Announce Study Met Its Primary Objective

    read more 

Pages

For more information please contact: pressoffice@kedrion.com